Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04766125
Other study ID # AUPsych
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 18, 2021
Est. completion date December 2024

Study information

Verified date December 2023
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study investigates the effect of adverse event information on adverse event occurrence in patients undergoing elective cardiac surgery in a two-armed, randomized study. One group will receive standard information about adverse events; the second group will receive a standardised elaboration of the standard information. Hypothesis: Elaborated information about adverse events will increase adverse event occurrence, mediated by expectations and anxiety, and moderated by coping style.


Description:

If quality assessment indicates that the protocol was not followed adequately, participants will be excluded from data analysis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 103
Est. completion date December 2024
Est. primary completion date December 15, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Adults (18 and older) undergoing elective cardiac surgery at the Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital Exclusion Criteria: - Patients who have previously had cardiac surgery - Cardiac surgery with deep hypothermia (<32 degrees Celsius) - Acute surgery - Patients with psychiatric or neurological disease who are unable to collaborate with the study protocol - Patients who do not speak/read Danish

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Adverse event information
All patients have access to the standard material about adverse events related to the surgery. One arm will additionally receive elaborated adverse event information from a nurse and a surgeon

Locations

Country Name City State
Denmark Aarhus University Aarhus

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus Aarhus University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of adverse events Assessed on day four
Secondary Number of adverse events Assessed on day 30, 90, and 180
Secondary Intensity of experienced adverse events Assessed on day four, 30, 90, and 180
Secondary Hospital readmission Assessed on day 180
Secondary Occurrence of specific adverse events Assessed on day four, 30, 90, and 180